These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group. Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674 [TBL] [Abstract][Full Text] [Related]
5. Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome. Lai X; Liu L; Zhang Z; Shi L; Yang G; Wu M; Huang R; Liu R; Lai Y; Li Q Bone Marrow Transplant; 2021 Jul; 56(7):1635-1641. PubMed ID: 33608657 [TBL] [Abstract][Full Text] [Related]
6. Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation. Park JE; Choi YH; Cheon JE; Kim WS; Kim IO; Ryu YJ; Kim YJ; Hong CR; Kang HJ Eur Radiol; 2018 Jun; 28(6):2291-2298. PubMed ID: 29294155 [TBL] [Abstract][Full Text] [Related]
8. Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease. Miyazawa M; Yanagi M; Chiba T; Kido H; Matsuo T; Nishitani M; Orita N; Takata N; Hayashi T; Seki A; Nakagawa H; Nio K; Terashima T; Iida N; Yamada S; Takatori H; Shimakami T; Arai K; Yamashita T; Mizukoshi E; Honda M; Yamashita T Intern Med; 2024 Jun; 63(11):1563-1568. PubMed ID: 37839881 [TBL] [Abstract][Full Text] [Related]
9. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study. Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. Bonifazi F; Barbato F; Ravaioli F; Sessa M; Defrancesco I; Arpinati M; Cavo M; Colecchia A Front Immunol; 2020; 11():489. PubMed ID: 32318059 [TBL] [Abstract][Full Text] [Related]
11. Ibrutinib Induces a Dramatic Improvement for Idiopathic Refractory Ascites Following Allogeneic Hematopoietic Cell Transplantation. Tazoe K; Nishimoto M; Yamamoto A; Makuuchi Y; Kuno M; Okamura H; Nakashima Y; Tanaka S; Ohsawa M; Hino M; Nakamae H Intern Med; 2023 Sep; 62(18):2737-2741. PubMed ID: 36754405 [TBL] [Abstract][Full Text] [Related]
12. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study. Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ; Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079 [TBL] [Abstract][Full Text] [Related]
13. Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation. Lewis C; Kim HT; Roeker LE; Cutler C; Koreth J; Nikiforow S; Armand P; Gootpu M; Romee R; Glotzbecker B; Nageshwar P; Antin JH; Alyea EP; Richardson P; Soiffer RJ; Ho VT Biol Blood Marrow Transplant; 2020 Mar; 26(3):529-539. PubMed ID: 31678537 [TBL] [Abstract][Full Text] [Related]
14. Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease. Madenci AL; Stetson A; Weldon CB; Lehmann LE Pediatr Transplant; 2016 Aug; 20(5):687-91. PubMed ID: 27373552 [TBL] [Abstract][Full Text] [Related]
15. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577 [TBL] [Abstract][Full Text] [Related]
18. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Carreras E; Díaz-Beyá M; Rosiñol L; Martínez C; Fernández-Avilés F; Rovira M Biol Blood Marrow Transplant; 2011 Nov; 17(11):1713-20. PubMed ID: 21708110 [TBL] [Abstract][Full Text] [Related]
19. Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation. Chevallier P; Prebet T; Turlure P; Hunault M; Vigouroux S; Harousseau JL; Blaise D; Ifrah N; Milpied N; Mohty M Bone Marrow Transplant; 2010 Jan; 45(1):165-70. PubMed ID: 19584826 [TBL] [Abstract][Full Text] [Related]